117 related articles for article (PubMed ID: 8719708)
1. NMDA receptor antagonist MK-801 down-regulates rat striatal proenkephalin and protachykinin mRNAs.
Zhang F; Van Bree L; Albala N; Verslype M; Vanderhaeghen JJ
Neurochem Int; 1996 Feb; 28(2):189-92. PubMed ID: 8719708
[TBL] [Abstract][Full Text] [Related]
2. Acute treatment with the N-methyl-D-aspartate receptor antagonist MK-801: effect of concurrent administration of haloperidol or scopolamine on preproenkephalin mRNA levels of the striatum and nucleus accumbens of the rat brain.
Noailles PA; Villegas M; Ledoux M; Lucas LR; McEwen BS; Angulo JA
Neurosci Lett; 1996 Jan; 202(3):165-68. PubMed ID: 8848257
[TBL] [Abstract][Full Text] [Related]
3. MK-801 prevents dopamine D1 but not serotonin 2A stimulation of striatal preprotachykinin mRNA expression.
Campbell BM; Walker PD
Neuroreport; 2001 Apr; 12(5):953-5. PubMed ID: 11303767
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with dizocilpine maleate increases the number of striatal neurons expressing the D2 receptor gene.
Lannes B; Bernard V; Bloch B; Micheletti G
Neuroscience; 1995 Mar; 65(2):431-8. PubMed ID: 7539897
[TBL] [Abstract][Full Text] [Related]
5. Locomotor-activity-induced changes in striatal levels of preprotachykinin and preproenkephalin mRNA. Regulation by the dopaminergic and glutamatergic systems.
Liste I; Rodriguez-Pallares J; Caruncho HJ; Labandeira-Garcia JL
Brain Res Mol Brain Res; 1999 Jun; 70(1):74-83. PubMed ID: 10381545
[TBL] [Abstract][Full Text] [Related]
6. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
Van De Witte SV; Groenewegen HJ; Voorn P
Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of forebrain proenkephalin mRNA subsequent to NMDA receptor blockade.
Angulo JA; Watanabe Y; Cadet J; Ledoux M; McEwen BS
Eur J Pharmacol; 1993 Feb; 244(3):317-8. PubMed ID: 8458404
[TBL] [Abstract][Full Text] [Related]
8. NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum.
Wang JQ; Daunais JB; McGinty JF
Synapse; 1994 Dec; 18(4):343-53. PubMed ID: 7886627
[TBL] [Abstract][Full Text] [Related]
9. Chronic blockade of muscarinic cholinergic receptors by systemic trihexyphenidyl (Artane) administration modulates but does not mediate the dopaminergic regulation of striatal prepropeptide messenger RNA expression.
Mavridis M; Rogard M; Besson MJ
Neuroscience; 1995 May; 66(1):37-53. PubMed ID: 7637873
[TBL] [Abstract][Full Text] [Related]
10. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
Campbell BM; Kreipke CW; Walker PD
Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of neostriatal preproenkephalin and preprotachykinin mRNA abundance by chronic treatment with the kainate/quisqualate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione in the rat brain.
Villegas M; Angulo JA
Neurosci Lett; 1995 May; 191(1-2):51-4. PubMed ID: 7659290
[TBL] [Abstract][Full Text] [Related]
12. Chronic dizocilpine maleate (MK-801) treatment suppresses the effects of nigrostriatal dopamine deafferentation on enkephalin but not on substance P expression in the rat striatum.
Hajji MD; Salin P; Kerkerian-Le Goff L
Eur J Neurosci; 1996 May; 8(5):917-26. PubMed ID: 8743739
[TBL] [Abstract][Full Text] [Related]
13. AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with L-dopa.
Périer C; Marin C; Bonastre M; Tolosa E; Hirsch EC
Eur J Neurosci; 2002 Dec; 16(11):2236-40. PubMed ID: 12473092
[TBL] [Abstract][Full Text] [Related]
14. Activation of c-fos mRNA in the brain by the kappa-opioid receptor agonist enadoline and the NMDA receptor antagonist dizocilpine.
Panegyres PK; Hughes J
Eur J Pharmacol; 1997 Jun; 328(1):31-6. PubMed ID: 9203564
[TBL] [Abstract][Full Text] [Related]
15. Elevation of striatal and accumbal preproenkephalin, preprotachykinin and preprodynorphin mRNA abundance subsequent to N-methyl-D-aspartate receptor blockade with MK-801.
Angulo JA; Williams A; Ledoux M; Watanabe Y; McEwen BS
Brain Res Mol Brain Res; 1995 Mar; 29(1):15-22. PubMed ID: 7769991
[TBL] [Abstract][Full Text] [Related]
16. Sensitization of the striatal dopaminergic system induced by chronic administration of a glutamate antagonist in the rat.
Lannes B; Micheletti G
Neurosci Biobehav Rev; 1997 Jul; 21(4):417-24. PubMed ID: 9195599
[TBL] [Abstract][Full Text] [Related]
17. Uncompetitive antagonists of the N-methyl-D-aspartate (NMDA) receptors alter the mRNA expression of proteins associated with the NMDA receptor complex.
Lindén AM; Väsänen J; Storvik M; Lakso M; Korpi ER; Wong G; Castrén E
Pharmacol Toxicol; 2001 Feb; 88(2):98-105. PubMed ID: 11169168
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the levels of NMDA receptor subunit mRNA and the bindings of [3H]MK-801 in rat brain by chronic infusion of subtoxic dose of MK-801.
Oh S; Kim YH; Hann HJ; Lee HL; Choi HS; Kim HS; Ho IK
Neurochem Res; 2001 May; 26(5):559-65. PubMed ID: 11513485
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels.
Cenci MA; Campbell K; Björklund A
Neuroscience; 1993 Nov; 57(2):275-96. PubMed ID: 8115038
[TBL] [Abstract][Full Text] [Related]
20. Effects of the NMDA receptor antagonist MK-801 on short-interval timing in rats.
Miller JP; McAuley JD; Pang KC
Behav Neurosci; 2006 Feb; 120(1):162-72. PubMed ID: 16492126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
